Status:
COMPLETED
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
Lead Sponsor:
Poitiers University Hospital
Conditions:
Memory Complaint
Alzheimer Disease
Eligibility:
All Genders
Up to 90 years
Phase:
NA
Brief Summary
Alzheimer disease is a frequent disease in the late ages that results in global alteration of cognitive functions. In which memory complaint can be isolated in the early stages. Physiopathology of ne...
Eligibility Criteria
Inclusion
- Memory complaint, leading to a medical visit at the Centre Mémoire de Ressources et de Recherche (CMRR) of Poitiers, and for which an MRI is needed in routine exploration.
- Age inferior at 90 years old
- Mini Mental State Examination (MMSE) score between 20 and 30
- Patient without guardianship measure, without restricted liberty.
- Patient who benefits from social security
Exclusion
- Vascular, tumor, inflammatory pathology diagnosed by MRI
- Other diagnosed neurodegenerative disease than Alzheimer disease
- Other non neurodegenerative neurological disease
- Vital risk at short term
- Severe and uncontrolled psychiatric disease
Key Trial Info
Start Date :
April 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03863041
Start Date
April 8 2019
End Date
June 15 2023
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU of Poitiers
Poitiers, France